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This paper presents a description of Peru’s experience with 
pandemic H1N1 influenza 2009. It is based on data from four 
main surveillance systems: a) ongoing sentinel surveillance 
of influenza-like illness cases with virological surveillance of 
influenza and other respiratory viruses; b) sentinel surveillance 
of severe acute respiratory infections and associated deaths; c) 
surveillance of acute respiratory infections in children under the 
age of five years and pneumonia in all age groups; and d) case and 
cluster surveillance. On 9 May 2009, the first confirmed case of 
pandemic H1N1 influenza in Peru was diagnosed in a Peruvian 
citizen returning from New York with a respiratory illness. By July, 
community transmission of influenza had been identified and until 
27 September 2009, a total of 8,381 cases were confirmed. The 
incidence rate per 10,000 persons was 4.4 (in the 0–9 year-olds) 
and 4.1 (in the 10–19 year-olds). During epidemiological weeks 
(EW)* 26 to 37, a total of 143 fatal cases were notified (a case 
fatality of 1.71%, based on confirmed cases). The maximum peak 
in the number of cases was reached in EW 30 with 37 deaths. 
Currently, the impact of the pandemic in the Peruvian population 
has not been too severe, and fortunately, healthcare centres have 
not been overwhelmed. However, the future of this pandemic 
is uncertain and despite the fact that our country has not been 
seriously affected, we should be prepared for upcoming pandemic 
waves.
Introduction
Peru is a South American country that is divided by the Andes 
Mountains into three distinct natural regions (coastal desert, 
highlands and jungle region) all extending the entire length of the 
country. The coastal desert has limited rainfall (<20 cm per year) 
with temperatures ranging between 15 and 30°C, and Lima, the 
main and capital city, is located in the central part of this region. 
The highlands that include cities located over 2,000 m above sea 
level experience high levels of rainfall and temperatures ranging 
between -2 and 15°C. Finally, in the jungle region rainfall exceeds 
200 cm per year, and cities are located close to sea level with 
temperature ranging from 18 to 32°C [1].
Since 1998, the Ministry of Health (MoH) of Peru has conducted 
virological surveillance of influenza and other respiratory viruses, 
and in 1999 surveillance of acute respiratory infections (ARI) 
and pneumonia cases and associated deaths was implemented. 
In 2006, the MoH established a sentinel surveillance system of 
influenza-like illness (ILI) cases in all the three regions of the 
country, in order to strengthen the National Surveillance Network 
[2]. Through these systems, influenza circulation in Peru has 
been detected throughout the year in coastal and jungle regions, 
and seasonal circulation during winter time has been identified 
in the highland region [3]. As a response of the World Health 
Organisation’s (WHO) global pandemic alert, the MoH established 
two additional surveillance systems: a case and cluster surveillance, 
and surveillance for severe acute respiratory infection (SARI) and 
SARI deaths.
On 9 May 2009, the first confirmed case of pandemic H1N1 
influenza in Peru was diagnosed in a Peruvian citizen returning 
from New York with a respiratory illness. Since then, the influenza 
A(H1N1)v virus has spread rapidly throughout the country [4]. In 
this context of preparation and response, this paper presents a 
description of Peru’s experience with the H1N1 influenza pandemic 
using data from the different surveillance systems in Peru.
Methods
The pandemic was described using data from four different 
surveillance systems, which are summarised below. All four systems 
report their data to the MoH. Case and cluster investigation was 
temporarily carried out at the beginning of the epidemic.
Sentinel surveillance of influenza-like illness cases and 
virological surveillance
Sentinel surveillance has been implemented in 50 health 
centres in the country. Nasal or pharyngeal swabs were processed 
at the Instituto Nacional de Salud (National Institute of Health, 
INS) and the Naval Medical Research Center Detachment (NMRCD) 
as previously described [3].
Case and cluster investigation 
On 9 May 2009, after the WHO issued a global pandemic alert, a 
surveillance system base on the case definition for pandemic H1N1 
influenza was established by the MoH to define the procedures of 
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detection, notification, investigation, follow-up and epidemiological 
control of the H1N1 influenza in Peru [5,6]. A suspected case 
was defined as any person with a sudden onset of fever (>38ºC) 
and at least one of the following symptoms: cough or sore throat 
within seven days of symptoms onset, in an area where confirmed 
pandemic H1N1 influenza cases were reported or epidemiologically 
linked to a close contact of a confirmed case. A confirmed case 
was defined as any person with a positive result in the RT-PCR for 
influenza A(H1N1)v virus. This system was stopped on 7 July with 
the change to the mitigation phase.
Surveillance for severe acute respiratory infections and 
associated deaths
In July 2009, when community transmission of influenza was 
identified, the MoH of Peru intensified surveillance efforts to 
reinforce the sentinel surveillance of SARI [7]. SARI was defined 
as any patient, with sudden fever >38ºC, together with cough or 
sore throat and respiratory distress who needed medical care in a 
hospital. Hospitalisation was defined as a patient spending at least 
one night in a hospital or healthcare center. An online platform with 
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Confirmed pandemic H1N1 influenza cases by onset of symptoms, Peru, 6 May-25 September 2009 (n=7,886) 
* for whom date of onset was available.
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information of hospitalisation, comorbidities, outcomes, treatment 
and other variables was established.
Acute respiratory infections, pneumonia and pneumonia deaths 
surveillance 
This system was optimised to follow up the spread of the 
pandemic. ARI included all children under the age of five years, 
while pneumonia cases and deaths were reported for all age groups.
Laboratory analysis 
From nasal and/or oropharyngeal swabs, RT-PCR assays for the 
detection of influenza A(H1N1)v virus were performed at the INS 
and NMRCD as described by United States Centers for Disease 
Control and Prevention [8]. At NMRCD in Lima, the specimens 
were stored at -70ºC, and later inoculated for virus isolation and 
identification [3] .  An online official system (NETLAB-INS) was 
established to access the results.
Control measures 
When the active surveillance system was in place, case clusters 
were identified by sampling symptomatic cases. Control measures 
included the use of respiratory masks, increased hygiene (hand 
washing) and administration of antiviral drugs (oseltamivir) to all 
suspected and confirmed cases and their contacts during this 
containment phase [4]. Following the WHO pandemic alert, travel 
restrictions to Mexico were put in place on 30 April and measures 
were taken to increase awareness of travellers of the new influenza 
virus. Furthermore, active surveillance of febrile patients was 
established in all airports, and a telephone hotline was established 
to receive reports from the population on respiratory disease 
and house identification of cases and contacts [4]. During the 
subsequent mitigation phase,  antiviral treatment was established 
on 21 July and it was focused on the high-risk group (pregnant 
women, cases under five years or over 60 years of age, or patients 
with SARI or a risk comorbidity) [4].
The clinical-epidemiological forms of the cases were entered into 
a database (NMRCD) or directly into an online platform on a website 
of the Dirección General de Epidemiología (General Directorate of 
Epidemiology, DGE).
Results  
Sentinel surveillance of influenza-like illness cases and 
virological surveillance
We have previously reported the results of the sentinel 
surveillance system in Peru from June 2006 to May 2008 [3]. 
Until 27 September, approximately 1,122 cases of pandemic 
H1N1 influenza (13.4% of the confirmed cases) were identified 
by this system. During the pandemic, the implementation of this 
surveillance system allowed us to identify the first outbreak of 
community transmission (18 May) with 11 confirmed cases in one 
of the surveillance sites (Huanuco province) located in the highland 
region of Peru.
T a b l e
Comorbidities and/or risk conditions detected in pandemic 
H1N1 influenza cases with fatal outcome, Peru, 9 May-19 
September 2009 (n=143*)
Comorbidity and/or risk condition (N=143) n (%)
No comorbidity or risk condition 35 (24.5)
Comorbidity and/or risk condition 108 (75.5)
          Metabolic 36 (25.2)
          Cardiovascular 30 (21.0)
          Respiratory 16 (11.2)
          Neurological 14 (9.8)
          Renal 13 (9.1)
          Genetic 13 (9.1)
          Other 10 (7.0)
          Pregnancy and puerperium 6 (4.2)
          Rheumatologic 6 (4.2)
          Infectious 5 (3.5)
          Digestive 4 (2.8)
          Cancer 3 (2.1)
* Multiple answers were possible
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infected during the influenza pandemic, Peru 2009, 9 May-
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Cases of severe acute respiratory infections, Peru, 
EW22-EW37, 2009 (n=1,458)
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Case and cluster investigation 
Description of cases
Until 27 September 2009, a total of 8,381 cases of pandemic 
H1N1 influenza have been confirmed, including 143 deaths. A 
total of 4,263 confirmed cases (52%) were males. The subjects’ 
age ranged from ≤1 year to 80 years, with a median age of 19 
years. Seventy-five percent of the cases were under 30 years-old 
and only 3.15% were older than 60 years. ILI cases were notified 
in all departments (administrative regions) of Peru, but Lima and 
Callao together notified almost 40% of the cases. 
The risk of infection was greater in those younger than 20 years, 
probably associated with sustained transmission within schools. 
The incidence rates per 10,000 persons were 4.4 and 4.1 among 
the 0-9 year-olds and the 10-19 year-olds, respectively (Figure 
1). During the containment phase, the large number of suspected 
cases that were detected (close to 400 per day) led to a delay in 
the generation of laboratory results by INS and NMRCD. When the 
containment phase ceased on 7 July, laboratory testing was focused 
on SARI patients. 
After 13 June (epidemiological week EW 23), an increase in the 
daily number of ILI cases was identified with a peak on 22 June 
(EW 25), as shown in Figure 2. This was followed by a consistent 
decrease in the number of cases especially in Lima and Callao. 
Further, the percentage of positive samples increased from 10% 
(EW23) to 70% (EW 25) and then started to decrease.
While the first epidemic peak occurred in Lima and Callao, 
secondary peaks in the epidemic curve correspond to the epidemic 
wave in the rest of Peru. The aggregated epidemic curve is 
multimodal due to the sum of local epidemics at different spatial 
locations where the novel influenza virus arrived at different times.
Description of clusters
The onset of symptoms of the first case was on 9 May 2009. 
Following the index case, our surveillance system detected many 
isolated imported cases that generated clusters of different size. 
We detected and investigated six clusters associated with persons 
returning from countries with or without demonstrated transmission 
at the time. These countries included the Dominican Republic, 
Mexico, Argentina and the US. Two of these clusters led to 
community transmission in Peru. These clusters will be described 
in depth elsewhere.
Surveillance for severe acute respiratory infections and 
associated deaths surveillance
After the switch of the surveillance strategy from the containment 
to the mitigation phase (7 July) as described above, the epidemic 
trend was monitored through the detection of SARI cases. At the 
time of writing this report, the trend of SARI cases for the whole 
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of Peru is slowly decreasing. In Peru, the peak was reached during 
EW 28, followed by a decrease in SARI cases (Figure 3). In the 
northern regions of the country, the peak was reached during EW 
34, and in the southern regions a bimodal curve was observed with 
two peaks at EWs 28 and 34 (data not shown).
SARI deaths 
During EWs 26-37, a total of 143 deaths associated with SARI 
were notified in 14 out of the 24 departments comprising Peru, 
a case fatality percentage of 1.63%, based on confirmed cases. 
Almost half of the deaths were recorded in the city of Lima and 
the port of Callao. The maximum peak was reached at EW 30 with 
37 deaths. After that, the number of fatalities decreased to two 
cases in EW 37.
The median age of deaths was 39 years (range: 0-85 years) and 
54% were women. The fatality rate was greater (7.63%) in persons 
over the age of 59 years, whereas the rate in the younger age groups 
(under 19 years of age) was lower than 1 (Figure 4). 
In 32 of the deaths (24%), there were no recorded underlying 
conditions. Six of the deaths (4.5%) were in pregnant women 
or women in puerperium; six deaths were in cases with Down 
syndrome; 23 in cases with obesity; nine in cases with diabetes 
mellitus type 2 (three of them associated with obesity) (Table).
Acute respiratory infections, pneumonia and pneumonia 
fatalities surveillance 
The epidemic curve of pneumonia cases among 5-59 year-olds 
in Lima and Callao increased in EW 26, reached the peak in EW 
28 when schools were temporarily closed for three weeks. Following 
this measure, the number of cases decreased as shown in Figure 5.
Control measures 
Between 24 April and 4 July 2009, no cases were identified 
in nearly 500,000 screened travellers, and hence the screening 
system at airports was deemed ineffective and was suspended. The 
first imported cases in travellers were identified who reported to the 
telephone hotline centre implemented by the MoH.
Discussion
Surveillance of pandemic H1N1 influenza in Peru provided 
valuable information about the behaviour of the pandemic in a 
developing southern hemisphere country. Lessons can be learned 
regarding the public health impact, prevention and control, impact 
on health services, and effective surveillance.
Public health impact of the pandemic
Lima, the largest city with a population of eight million, has the 
main international airport and was the first city in Peru affected by 
the new influenza virus. In addition, all laboratory testing for the 
country is centralised in this city. These factors could explain the 
fact that almost 30% of the initial confirmed cases of pandemic 
H1N1 influenza were located in Lima. 
Until September 2009, Peru identified over 8,000 confirmed 
cases, but this is only the tip of the iceberg. The pattern of 
dissemination of this pandemic in Peru is associated with people’ 
mobility and population density, and more populated areas tend to 
be affected earlier than smaller populations. Access to laboratory 
resources across Peru is not uniform and could have affected this 
transmission pattern. Moreover, distant and geographically isolated 
locations may have not reported cases before the appearance 
of severe cases who require mechanical ventilation in hospital 
settings.
We observed that while a great number of people under the age 
of 24 years were infected, this group had a lower probability of dying 
from influenza. The lower frequency of pandemic H1N1 influenza 
cases among those over 59 years of age supports the hypothesis that 
people who were exposed to influenza A(H1N1) during childhood 
before the 1957 have a certain extent of immunological protection 
to the influenza A(H1N1)v virus [9]. Such a consistent pattern has 
been reported in other regions including Mexico, the US, Europe, 
Australia and New Zealand [10-11]. When infected, however, these 
older patients had a high risk of fatality, in our country as reported 
in other regions [12].
Cases of pandemic H1N1 influenza in Peru presented 
predominantly mild and self-limiting illness, and although fever 
and cough were the most common clinical manifestations, 
many subclinical or asymptomatic cases should have circulated 
in the country. The majority deaths related to pandemic H1N1 
influenza (75.5%) had a reported underlying medical condition. 
In fact, almost half of the deaths had conditions classified as 
high risk in other countries [13]. The fact that 25% of the cases 
did not have high risk conditions suggest that additional factors 
such as immunological status or access to healthcare could have 
contributed to the fatal outcome.
Our case definitions were very specific, but allowed us to develop 
interventions and to sample suspected cases to help us identify 
clusters and follow virus dissemination patterns throughout the 
country.
Control measures and limitations of the study
Initial control measures established by the MoH of Peru included 
travel restrictions and quarantine of suspected travellers following 
WHO recommendations [14]. However, these actions were not 
effective and did not significantly delay the spread of the virus 
into other nations including Peru. Also, many travellers could have 
enter the country during the incubation period, as detected in other 
countries [15]. The telephone hotline was found to be useful in 
identifying case clusters of suspected and confirmed cases and 
following the dissemination of the virus throughout the country 
[16]. House identification of cases and contacts and follow-up 
procedures involved a great deal of human resources. As a result, 
those activities were discontinued.
We believe that the epidemiological surveillance system 
recommended by WHO, i.e. early case detection and investigation, 
comprehensive assessment and pandemic monitoring [17], was 
essential for the development of adequate control measures. At 
the beginning of the pandemic, it is possible that our surveillance 
systems failed to detect many cases, especially those with mild 
disease. Many patients may not have visited a health centre or may 
not have had access to laboratory services. ARI surveillance was 
not as helpful as we expected, due to the limitations in detecting 
cases among outpatients. The SARI surveillance system, however, 
was useful because it allowed us to monitor the pandemic trends 
in all age groups and among the more severe cases. It also allowed 
us to evaluate the impact of the pandemic.
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Conclusion
It is well known that previous pandemics have presented a 
second or third wave of morbidity and mortality. These multiple wave 
profiles could be associated with spatial, seasonal, hemispheric 
(north, south, tropics) or climatic (humidity, temperature) factors 
[18,19]. Currently, the impact of the pandemic in the Peruvian 
population has not been severe, and fortunately healthcare centres 
have not been overwhelmed. However, the future of this pandemic 
is uncertain and despite the fact that our country has not been 
seriously affected, we should be prepared for upcoming pandemic 
waves.
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